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Abstract – Cytokines produced by T helper (Th) cells are important in orchestrating the immune response
during health and disease. Recent reports indicated that cytokine mRNA expression in foals is often
quantitatively lower than that of adult horses suggesting that foal T cells are not fully mature. Here,
peripheral blood mononuclear cells from foals and adult horses were stimulated with phorbol 12-myristate
13-acetate and analyzed for intracellular interferon-gamma (IFN-c), interleukin-4 (IL-4) and IL-10
production, representing the Th1, Th2 and regulatory TR1 cell phenotypes respectively, by ﬂow cytometry.
In agreement with previous reports, all three cytokines were quantitatively reduced in foals compared to
adults. However, the balance between Th1 and Th2 cytokines (IFN-c/IL-4 ratio) showed a clear Th1-biased
response in foals by 6 and 12 weeks of life, while similar IFN-c/IL-10 ratios were found in foals and adult
horses. By day 5 after birth, intracellular IFN-c production by foal CD4
+ and CD8
+ Tcells resembled that in
adults. Overall, IL-4 production was low in foals. IL-4
+ cells peaked at day 5 of age when IL-4 was mainly
produced by IgE
+ cells. Relative percentages of IL-4
+ Th2 cells were signiﬁcantly lower in foals at all time
points. The data suggested that equine neonates and young foals have an impaired Th2 response, that the
immune response of foals is Th1 biased, that IFN-c production by Th and cytotoxic T cells is qualitatively
similar to adult horses, and regulatory IL-10 production by Tcells is developmentally mature in foals during
the ﬁrst three months of life.
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1. INTRODUCTION
After activation T helper (Th) cells develop
into different subsets called Th1, Th2, Th17
and regulatory T cells (Treg). These T cell
subsets express different cytokines and mediate
distinct effector functions during immune
responses. Th1 cells are characterized by
interferon-gamma (IFN-c) production and are
required in defending against infection with
many intracellular pathogens [36]. Th2 cells
produce interleukin-4 (IL-4), IL-5, IL-13 and
IL-31. They promote the development of anti-
body mediated immune responses against extra-
cellular bacteria and parasites [27]. Tregs have
major functions in maintaining peripheral toler-
ance, immune regulation, and in limiting
inﬂammation during autoimmune diseases
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Article published by EDP Sciences[39]. Treg cells express transforming growth
factor beta (TGF-b) and/or IL-10 [14]. The
most recently discovered Th cell subset is
Th17 characterized by the secretion of IL-17.
Th17 cells promote inﬂammation, play a crucial
role in the clearance of pathogens during the
host immune defense, and also induce inﬂam-
matory processes in autoimmune diseases [17].
In horses, Th cell subset detection was ham-
pered by the lack of reagents to key cytokines
characterizing the different Th cell responses.
During the past few years, reagents to detect
the production of several equine cytokines
became available including monoclonal anti-
bodies (mAb) to equine IL-4 [42] and IL-10
[43]. In addition, various groups have previ-
ously shown that a mAb to bovine IFN-c
cross-reacts with equine IFN-c [32, 41]. This
antibody enabled the detection of intracellular
IFN-c production during infection with equine
herpesvirus type 1 (EHV-1) and equine inﬂu-
enza virus [6, 30]. Besides the lack of reagents
to cytokines, Th cell phenotyping in horses is
still restricted by the availability of T cell mark-
ers. Although antibodies to CD3, CD4 and
CD8 were developed and characterized by
two workshops on equine leukocyte antigens
[18, 21], reagents for T cell receptors, natural
killer cells or CD25 to better identify Treg cells
are still missing. Thus far, the only Treg cell
subsets that were characterized in horses were
(1) a population of CD4
+ T cells that simulta-
neously produces IFN-c and IL-10 [43], and
(2) a population of CD4
+ foxp3 expressing
cells that was recently characterized in periphe-
ral blood mononuclear cells (PBMC) and endo-
metrial cup cells [8]. The CD4
+/IFN-c
+/IL-10
+
Treg cell subset was named TR1 cells according
to a similar cell population identiﬁed in humans
and mice [14].
Many investigations have focused on differ-
ences in cytokine mRNA expression between
equine PBMC isolated from neonates, foals
and adult horses. Several parameters of the
humoral and cellular immune response of foals
were found to be decreased compared to that of
adult horses [5, 7, 23, 33] causing some authors
to conclude that the foal immune system is
‘‘immunodeﬁcient’’. It has also been suggested
that the reduced ability of equine neonates to
produce IFN-c and other pro-inﬂammatory
cytokines enhances their susceptibility to intra-
cellular pathogens [5, 7]. For instance, infection
with the intracellular bacterium Rhodococcus
equi causes severe respiratory disease in foals
but mild or no clinical signs in adult horses
[15]. However, in response to antigen stimula-
tion, foal immune cells increased the gene
expression of certain cytokines. After infection
with R. equi, monocyte-derived dendritic cells
from foals increased IL-12 mRNA expression
more than cells from adult horses [11]. Foal
PBMC also showed a clear up-regulation of
IFN-c mRNA, a decreased IL-4 gene expres-
sion and greater IFN-c/IL-4 transcript ratios in
response to R. equi i n f e c t i o nc o m p a r e dt oa d u l t
horses [16].
Similarly, IFN-c production in response to
EHV-1 infection was almost undetectable in
foals but increased with age [29]. However,
the IFN-c producing cells in foals and young
horses were identiﬁed as mainly CD8
+ cyto-
toxic T cells (CTL) [31] which are considered
to be associated with protection from disease
[3, 19]. In older horses, the EHV-1 speciﬁc T
cell response shifted towards a CD8
 pheno-
type resulting in a clear decrease in IFN-c pro-
ducing EHV-1 speciﬁc CTL in aged horses
[31]. These phenotypic variations in the IFN-c
producing effectors T cells were believed to
offer some explanation for age-dependent dif-
ferences in the susceptibility to clinical disease
induced by R. equi or EHV-1 in foals and adult
horses.
In addition, mRNA expression studies
described a generally decreased ability of neo-
natal PBMC to express IFN-c,T G F - b and
IL-1a transcripts in comparison to cells from
adult horses [5]. Other cytokines such as IL-8,
IL-12 and IL-23 were found to be increased
or similarly expressed in PBMC from neonates
compared to older foals [20]. Stimulation of
PBMC from foals with lipopolysaccharide
(LPS) and IFN-c also resulted in increased
IL-10 mRNA expression compared to PBMC
from adult horses [35].
These reports indicate that cytokine produc-
tion and T cell development in foals likely vary
depending on the cell type and the antigen-
speciﬁc stimulus. Because the cytokine network
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cells can be manifold, a better understanding
of the cytokine production by different immune
cells of the horse is required. Here, we com-
pared cytokine responses in foals and adult
horses to obtain a broader understanding on
the ontogeny of the Th cell response in healthy
foals. We analyzed for the ﬁrst time IFN-c,I L - 4
and IL-10 on a protein and cellular level using
intracellular staining and ﬂow cytometric analy-
sis. We also investigated the development of
Th1 cells (CD4
+/IFN-c
+), Th2 cells (CD4
+/IL-
4
+), the TR1 subpopulation of Treg cells
(CD4
+/IFN-c
+/IL-10
+)a n dC T L( C D 8
+/IFN-
c
+) during the ﬁrst three months of life. Charac-
terizing differences and similarities of adaptive
immunity in foals and adult horses is important
in assessing appropriate immune responses in
healthy foals, in identifying inappropriate
immune regulation in diseased foals, and in
developing improved or new vaccination strate-
gies for very young horses.
2. MATERIALS AND METHODS
2.1. Animals and blood sampling
Heparinized blood sample were obtained via jun-
gular venipuncture from 18 neonatal foals (day 1–2
after birth), 15 foals at day 5, and 15 foals each at
6 and 12 weeks of age, and 15 adult horses using
the BD Vaccutainer system (Becton Dickinson,
Franklin Lakes, NJ, USA). The horses consisted of
Warmbloods, Thoroughbreds, and Thoroughbred
crosses. The adult horse group was composed of 15
dams of the foals. The mares were between 8 to
22 years of age (median 14 years) and blood samples
for this study were obtained at 12 weeks after birth.
Foals were born and raised at the Cornell University
Equine Park during the 2007 and 2008 foaling sea-
sons. All animals were clinically healthy throughout
the study. After birth, the foals suckled colostrum
from their dams ad lib. On day 1, a blood IgG quan-
tiﬁcation was performed using the Snap Foal IgG test
(IDEXX laboratories, Westbrook, ME, USA). All
foals had serum IgG levels of > 800 mg/dL indicat-
ing sufﬁcient passive transfer of maternal
immunoglobulins.
All animal procedures were approved by the
Cornell University Institutional Animal Care and
Use Committee (Ithaca, NY, USA) and were in
accordance with the guidelines established by the
National Institutes of Health (Bethesda, MD, USA).
2.2. Cell isolation and ﬁxation
PBMC were isolated from heparinized blood by
density gradient centrifugation (Ficoll-Paque
TM Plus,
GE Healthcare, Piscataway, NJ, USA). A total of
6 · 10
6 cells/well were cultured in 6-well plates in
cell culture medium (DMEM containing 10% (v/v)
FCS, 1% (v/v) non essential amino acids, 2 mM
L-glutamine, 50 lM 2-mercaptoethanol, 50 lg/mL
gentamycin) with Brefeldin A (10 lg/mL; Sigma,
St. Louis, MO, USA) to block secretion of intracellu-
lar proteins. Aliquots of PBMC were either kept in
medium or were stimulated with phorbol 12-myris-
tate 13-acetate (PMA; 25 ng/mL) and ionomycin
(1 lM; both Sigma) to provoke cytokine production.
For a kinetic study on cytokine production, PBMC
from four adult mares were stimulated with PMA
a n di o n o m y c i nf o r2 ,4 ,6 ,8 ,1 8a n d2 4h .A l lo t h e r
stimulated samples and medium controls from foals
and adult horses were incubated for 4 h in a CO2
incubator. After incubation, the cells were washed
in PBS and ﬁxed in 2% formaldehyde for 20 min at
room temperature.
2.3. Intracellular cytokine staining
and phenotyping of T cells
Intracellular staining was performed in saponin
buffer (PBS, supplemented with 0.5% (w/v) BSA,
0.5% (w/v) saponin and 0.02% (w/v) NaN3). Mono-
clonal antibodies to equine IL-4 [42], equine IL-10
[43], and bovine IFN-c (MorphoSys, AbD Serotec,
Oxford, UK) were used for intracellular staining.
The later antibody was previously found to cross-
react with equine IFN-c [32, 41]. A murine IgG1 iso-
type control was included in the procedure using an
aliquot of the PBMC. After staining of around
1 · 10
6 ﬁxed PBMC for 20 min at room tempera-
ture, cells were washed twice with saponin buffer
a n do n c ew i t hP B S / B S A( P B S ,s u p p l e m e n t e dw i t h
0.5% (w/v) BSA and 0.02% (w/v) NaN3). For cell
surface staining of T cells, monoclonal antibodies to
equine CD4 (HB61A, VMRD, Pullman, WA,
USA), equine CD8 (CVS8, kindly provided by
Dr Paul Lunn) and equine CD3
1 were used. Staining
of IgE
+ cells was performed with monoclonal anti-
IgE 176 [40]. Cell surface staining was performed
in PBS/BSA for 10 min at room temperature. After-
wards, the cells were washed once with PBS/BSA
1 Wagner et al., unpublished data.
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bur ﬂow cytometer (BD Biosciences, San Diego, CA,
USA). A total of 30 000 events were measured per
sample. All antibodies were conjugated to Alexa ﬂu-
orochromes A647 or A488 (Molecular Probes, Invit-
rogen, Eugene, OR, USA) according to the protocol
provided by the supplier, except for the FITC conju-
gated anti-bovine IFN-c antibody.
2.4. Statistical analysis
A Shapiro–Wilk normality test was performed on
each data set and showed that several variables were
not Gaussian distributed. Thus, non-parametric test
were used for data analysis. The foal groups at vari-
ous time points were composed of animals living in
the same environment but did not represent sequen-
tial samples. Cytokine production in the foal and
adult groups and the cytokine ratios between age
groups were compared by a Kruskal–Wallis test fol-
lowed by Dunn’s pairwise tests. For example, the
total percentages of cytokine producing cells were
compared at the lowest age to 2nd lowest, 2nd lowest
to 3rd lowest, etc. For the cytokine ratios and the rel-
ative percentages of cytokine producing CD4
+ and
CD8
+ cells, we compared each of the foal groups
to the adults. The analysis was performed 2-tailed
and with 95% conﬁdence intervals. We used 2-sided
alpha = 0.05 for signiﬁcance and did not make addi-
tional adjustments for multiplicity beyond those
implicit within each Kruskal–Wallis test and its
Dunn’s test. The statistical calculations were per-
formed using the GraphPad Prism program, version
5.01 (GraphPad Software, La Jolla, CA, USA).
3. RESULTS
3.1. Cytokine production and T cell marker
expression in PBMC stimulated with PMA
and ionomycin
PBMC from four adult horses were stimu-
l a t e dw i t hP M Aa n di o n o m y c i nf o r2t o2 4h
to identify the optimal stimulation time for
cytokine production. Intracellular cytokines
were detectable at all time points of stimulation
(Fig. 1B) but not in non-stimulated cells
( 0.4% at all time points). The total percent-
ages of IFN-c or IL-10 producing cells showed
a signiﬁcant increase between 4 and 6 h of
stimulation (IFN-c p = 0.03; IL-10 p = 0.002)
and reached a plateau afterwards. The percent-
age of total IL-4 producing cells also showed
a tendency to increase during the ﬁrst 6 h with-
out being signiﬁcantly different from the previ-
ous time point. Between 8 and 18 h, IL-4
decreased slightly but signiﬁcantly (p =0 . 0 3 ) .
For IFN-c and IL-10, we also analyzed individ-
ual populations producing only one or both
cytokines during 24 h of stimulation (Fig.
1C). Similar to total IFN-c and IL-10 producing
cells, the single IFN-c
+ or IFN-c
+/IL-10
+ cells
increased signiﬁcantly between 4 and 6 h of
stimulation. Single IL-10
+ cells increased sig-
niﬁcantly between 2 and 4 h and then showed
a tendency to increase without signiﬁcant differ-
ences from one to the next time point and with
increasing variations between horses as indi-
cated by the high standard deviations at 18
and 24 h.
In addition, CD3, CD4 and CD8 expression
was compared in stimulated and non-stimulated
PBMC (Tab. I). In non-stimulated cells, the per-
centages of CD3
+,C D 4
+ and CD8
+ lympho-
cytes did not differ during 24 h of incubation.
Previous reports have shown that PMA and ion-
omycin stimulation reduced the expression of
CD4. Here, we observed that CD4 and CD8
expression decreased in PMA stimulated lym-
phocytes compared to non-stimulated cells,
while CD3 expression was not effected by the
treatment. Within the CD3
+ cells, the percent-
ages of cells expressing CD8 were up to two-
fold higher in non-stimulated samples than after
PMA stimulation. Signiﬁcant differences in the
stimulated samples were observed between 2
a n d4 h( p = 0.0498), and 4 and 6 h
(p = 0.0079). Longer stimulation did not alter
the percentage of CD8
+ cells any further. In
contrast, the expression of CD4 decreased con-
stantly in stimulated cells, with the exception of
as l i g h ti n c r e a s eb e t w e e n4a n d6ho fs t i m u l a -
tion (p = 0.0248). The ratios of CD4
+ T cells in
non-stimulated versus stimulated cells ranged
from 1.37 at 2 h, 2.41 at 4 h, up to 9.11 at
24 h.
Because one major goal of this study was to
investigate cytokine production in Th and TR1
cells, CD4 detection was crucial for the analysis
by ﬂow cytometry. All following experiments
used PMA and ionomycin stimulation for 4 h
Vet. Res. (2010) 41:47 B. Wagner et al.
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and ionomycin. PBMC were incubated in the presence of the secretion blocker Brefeldin A. Then, they were
ﬁxed and intracellular cytokine staining was performed. (A) Non-stimulated PBMC from a 6 week old foal
after 4 h of incubation in medium with Brefeldin A. The left plot shows the gating (R1) on peripheral blood
lymphocytes that was used for analysis of the data. The remaining three plots show a two-color staining of
non-stimulated lymphocytes using anti-CD4 and different anti-cytokine antibodies. Typically, cytokines
were not detected in equine peripheral blood lymphocytes in the absence of stimulation. Isotype controls for
cytokine staining generally resulted in less than 0.05% of detectable cells. (B and C): PBMC from 4 adult
horses were stimulated with PMA and ionomycin for up to 24 h and cytokine expression was measured at
various time points. (B) Total percentages of IFN-c, IL-10 and IL-4 producing cells in the lymphocyte
population, (C) Percentages of IFN-c
+/IL-10
+, IFN-c
+/IL-10
 and IFN-c
/IL-10
+ cells during 24 h of
stimulation. The data in B and C represent means and standard deviations. Differences in cytokine
expression from one to the next time point were compared by Student’s t-tests. ** p = 0.001 to < 0.01;
* p = 0.01 to 0.05; (D) PMA and ionomycin stimulated cells from foals of different ages and adult horses.
Double staining of IFN-c and IL-4 or (E) IFN-c and IL-10. The dot plots show one representative image
from a foal or horse of the respective age group.
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CD4 expression was still in an acceptable
range. Although cytokine production and CD4
and CD8 expression were slightly higher in
adult horses after 6 h compared to 4 h, we
did not perform stimulations for 6 h because
the cell recovery rate clearly decreased during
the ﬁrst 8 h of stimulation with PMA (data
not shown) and cells of neonates were often
very sensitive to the treatment resulting in even
higher cell losses.
3.2. Cytokine production in foals
at different ages
To analyze the production of IL-4, IFN-c
and IL-10 cytokines in foals during the ﬁrst
three months of life, PBMC were stimulated
in vitro and intracellular cytokine production
in lymphocytes was analyzed by ﬂow cytomet-
ric analysis. Non-stimulated PBMC were run as
experimental controls and did not contain
detectable amounts of IL-4, IFN-c and IL-10
(Fig. 1A) with the only exception being a small
but distinct population of IL-4 producing cells
evident in non-stimulated samples from 5-day
old foals. PMA treatment of PBMC obtained
from newborn and day 5 old foals resulted in
low numbers of cytokine producing cells
(Fig. 1D and E). Then, the total percentages
of cells producing IFN-c (Fig. 2A) and IL-10
(Fig. 2B) increased until 6 weeks of age and
stayed at a similar level by 12 weeks of age.
In contrast, the IL-4 production peaked in foals
at day 5, decreased slightly but not signiﬁcantly
by 6 weeks and did not differ between 6 and 12
weeks of age (Fig. 2C). For all three cytokines
analyzed in the foals, adult levels were not
reached by 12 weeks of age.
3.3. Ratios of IFN-c/IL-4 and IFN-c/IL-10
in foals and adult horses
Cytokines are mediators of the cellular
immune response and the balance of Th1,
Th2 and Treg cells crucially inﬂuences the ini-
tiation and outcome of the immune response.
One could hypothesize that comparable ratios
of respective cytokines might result in similar
immune responses in foals and adults, even if
total numbers of cytokine producing cells differ
with age. To analyze the relative concentrations
of cytokines in foals and adult horses, we calcu-
lated the ratios of IFN-c/IL-4 (Fig. 3A)a n d
IFN-c/IL-10 (Fig. 3B) using the total cytokine
production in equine lymphocytes stimulated
Table I. Flow cytometric analysis of T cell marker expression in equine PBMC (n = 4) after stimulation
with PMA and ionomycin (PMA) or in non-stimulated cells (med).
Cell population (%)
a Time of stimulation (hours)
24681 8 2 4
CD3
+ (med)
b 77.6 ± 9.4 79.3 ± 8.3 81.7 ± 7.4 79.9 ± 7.4 86.4 ± 5.9 86.3 ± 3.1
CD3
+ (PMA)
b 84.4 ± 3.6 83.5 ± 6.2 85.1 ± 6.3 86.9 ± 4.0 87.5 ± 3.6 87.5 ± 3.2
Ratio CD3
+ med/PMA 0.92 0.95 0.96 0.92 0.99 0.99
CD4
+ (med)
c 76.3 ± 1.3 75.7 ± 1.6 76.5 ± 1.1 76.7 ± 1.2 77.1 ± 2.2 75.8 ± 2.2
CD4
+ (PMA)
c 55.7 ± 3.5 31.4 ± 5.1 37.8 ± 6.0 26.8 ± 8.7 14.0 ± 10.4 8.3 ± 3.5
Ratio CD4
+ med/PMA 1.37 2.41 2.03 2.86 5.50 9.11
CD8
+ (med)
c 17.1 ± 1.2 18.2 ± 1.8 17.4 ± 1.2 17.2 ± 1.8 16.2 ± 1.3 15.4 ± 1.1
CD8
+ (PMA)
c 10.7 ± 2.0 8.8 ± 1.1 11.0 ± 1.5 11.5 ± 1.4 9.0 ± 1.2 8.9 ± 1.8
Ratio CD8
+ med/PMA 1.60 2.06 1.58 1.49 1.8 1.73
a The data in the table show means and standard deviations.
b For analysis of CD3
+ cells, a gate was set on lymphocytes and the percentages of CD3
+ cells were determined.
c CD4 and CD8 cells: The percentages show the relative amounts of CD4
+ or CD8
+cells within the population of
CD3
+ cells (= 100%).
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ratios in neonates at day 1–2 and day 5 after
birth were similar to adult horses. At 6 and 12
weeks of age the IFN-c/IL-4 ratios in foals were
signiﬁcantly increased compared to adult
horses. In contrast, the IFN-c/IL-10 ratios were
not signiﬁcantly different in neonates or foals
compared to adult horses (p =0 . 6 9 6 ) .
3.4. Phenotyping of IFN-c
+ T cells
To investigate whether phenotypic differ-
ences of IFN-c producing Tcells could be iden-
tiﬁed between foals and adult horses, cells were
double stained for IFN-c and with CD4 or CD8
to identify Th cells and CTL respectively
(Fig. 4). The percentages of IFN-c
+ cells within
the two T cell populations were determined.
Compared to adults, 1–2 days old foals had sig-
niﬁcantly fewer CD4
+/IFN-c
+ cells (Fig. 4B)
and a slightly increased but not signiﬁcantly
higher percentage of CD8
+/IFN-c
+ cells
(Fig. 4C). Five days old foals had a trend
towards greater percentages of CD4
+/IFN-c
+
cells and fewer CD8
+/IFN-c
+ cells compared
to adult horses, but these differences were not
signiﬁcant. The percentages of CD4
+ or
CD8
+/IFN-c
+ cells of older foals were similar
to adult horses.
A third Tcell population that simultaneously
produces IFN-c and IL-10 are TR1c e l l s .T h e s e
regulatory Tcells also express CD4. IFN-c
+/IL-
10
+ cells were clearly detectable in foals at 6
and 12 weeks of age (Fig. 4D) and represented
the majority of the IL-10
+ cells in foals and
adult horses (Fig. 1C and E). Previous studies
and data obtained here showed that
84.3 ± 3.3% of the IFN-c
+/IL-10
+ lymphocytes
are CD4
+ TR1 cells (Fig. 4E). Within the total
CD4
+/IFN-c
+ cell population of adult horses,
TR1 cells accounted for approximately 9%,
w h i l e9 1 %o ft h eC D 4
+/IFN-c
+ lymphocytes
produced IFN-c only, and thus represented
Th1 cells. In foals, the relative amounts of
IFN-c
+/IL-10
+ cells within the total IFN-c
+
cells was 2.4% at 5 days, 6.9% at 6 weeks
and 6.7% at 12 weeks of age. However, a
Figure 2. Total percentages of (A) IFN-c, (B)
IL-10 and (C) IL-4 producing lymphocytes in
neonates (n = 18), foals until 12 weeks of age
(n = 15) and in adult horses (n = 15). PBMC were
stimulated with PMA and ionomycin. The cells
were stained for intracellular cytokine production
and were analyzed by ﬂow cytometry. The per-
centages include all cells producing the respective
cytokine including double positive cells. The
horizontal lines within the data sets represent
medians. *** p < 0.001; ** p = 0.001 to < 0.01;
* p = 0.01 to 0.05; ns = not signiﬁcant.
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+/IL-10
+ cells
was only found for foals at day 5 of age com-
pared to adult horses (p < 0.001). The relative
amounts of IFN-c
+/IL-10
+ cells from older foals
did not differ from those of adult horses.
3.5. Phenotyping of IL-4
+ cells
IL-4 producing cells in non-stimulated
PBMC from foals directly after birth were pre-
viously shown to be CD4
 cells. The IL-4
+
cells had IgE bound to their surface and were
characterized as basophils. To determine
whether IL-4 production could be provoked in
T cells from neonates and foals, PBMC were
stimulated with PMA and ionomycin and dou-
ble stained for intracellular IL-4 and cell surface
CD4 or IgE.
PMA stimulation of PBMC from adult
horses consistently induced IL-4 production in
CD4
+ T cells (Fig. 5) resulting in 87% of
CD4
+/IL-4
+ cells and 5% of IgE
+/IL-4
+ cells.
Although the total percentages of IL-4
+ cells
in foals were signiﬁcantly lower than in adult
horses at all time points (Fig. 2C), the percent-
age of CD4
+/IL-4
+ cells consistently increased
from 8% at birth to 62% at 12 weeks of age
(Fig. 5B). In contrast, the percentage of IgE
+/
IL-4
+ cells progressively decreased from 95%
in newborn foals to 17% at 12 weeks of age.
In summary, PMA induced IL-4 production
by Th cells was almost undetectable in newborn
foals, when IL-4 was mainly produced by IgE
+
cells. Then, IL-4 production by Th cells
increased slowly with age. At 12 weeks of life,
the relative percentage of CD4
+ IL-4 producing
cells had still a tendency of being reduced com-
pared to adult horses. However, this difference
was not signiﬁcant anymore.
4. DISCUSSION
Cytokines are potent regulators of innate and
adaptive immune responses. Their ﬁne-tuning is
crucial for the successful development of
immunity and protection from disease. How-
ever, the interactions of cytokines with cells
are manifold and result in a complex network
of activating and suppressive mechanisms [1,
25, 27, 37, 38].
Cytokines produced by different Th cell sub-
sets play major roles in orchestrating the adap-
tive immune response during infectious disease.
The inability of foals to respond to infection or
vaccination comparable to that of adult horses
has often been interpreted to reﬂect ‘‘immuno-
deﬁciency’’ and was believed to be a reason
for the increased susceptibility of foals to intra-
cellular pathogens such as R. equi [5, 7, 20].
Other authors have suggested that foal immune
system exhibits a Th2-bias [5, 23, 26]. This
Figure 3. Ratios of (A) IFN-c
+/IL-4
+ and (B) IFN-c
+/IL-10
+ lymphocytes in foals up to 3 months of age
and adult horses. PBMC were stimulated with PMA and ionomycin. The cells were stained for intracellular
cytokine production and measured by ﬂow cytometry. The total percentages of IFN-c, IL-4 and IL-10
producing lymphocytes were determined and ratios were calculated for the respective cytokines. The
horizontal lines within the data points show the medians. *** p < 0.001; * p = 0.01 to 0.05.
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Page 8 of 14 (page number not for citation purpose)Figure 4. Flow cytometric analysis of CD4
+ and CD8
+ IFN-c producing lymphocytes. PBMC from foals of
different age groups and from adult horses were stimulated with PMA and ionomycin. The cells were
stained for intracellular IFN-c and cell surface CD4 or CD8 expression. (A) Flow cytometric analysis of one
representative horse per age group. (B) Relative percentages of CD4
+/IFN-c
+ and (C) CD8
+/IFN-c
+ T cells
in foals and adult horses within the IFN-c producing cells (= 100%). (D) Percentages of IFN-c
+/IL-10
+
lymphocytes in foals and adult horses. (E) A tri-color staining was performed on stimulated PBMC to
conﬁrm that the majority of the IFN-c
+/IL-10
+ cells are CD4
+ T cells. Gates were set on lymphocytes (see
Fig. 1A) and on IFN-c
+ cells (left panel). The IFN-c
+ lymphocytes were then analyzed for IL-10 and CD4
staining (right panel). The horizontal lines within the data sets B, C and D represent medians.
*** p < 0.001; ** p = 0.001 to < 0.01; ns = not signiﬁcant.
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adigm in neonatal mice indicating a Th2 domi-
nated immune response, although strong Th1
responses have been induced depending on
the experimental conditions [4, 12, 13]. In con-
trast, data on human neonatal T cells did not
support that Tcells are Th2 polarized and rather
point towards a Th1 or Th0 type response in
human neonates [2, 9, 22].
In this study, we analyzed the protein
expression of three key cytokines, representing
Th1 (IFN-c), Th2 (IL-4) and TR1 (IL-10 and
IFN-c) responses, to investigate the develop-
ment of Th cell responses in foals during the
ﬁrst three months of life. Previous studies on
the induction of adaptive immune responses
in foals and adult horses have focused on the
expression of mRNA [5, 11, 16, 20, 35]b u t
failed to provide detailed information about
the cellular source of cytokine production. For
example, IFN-c mRNA up-regulation in PBMC
could originate from several cell types such as
Th cells, CTL or NK cells and would not nec-
essarily represent a Th1 response. Similarly,
other authors have analyzed the production of
a single cytokine (IFN-c), at the protein level
with or without regard to the cell type [7, 29,
31]. This work has shown that IFN-c protein
and mRNA expression after PMA stimulation
of PBMC from foals attained adult levels at
around one year of age [7]. We also observed
reduced IFN-c production in neonates and older
foals compared to adult horses after PMA
stimulation. Similarly, the IL-10 and IL-4
production was clearly reduced in neonatal
and foal PBMC when compared to adult cells.
Figure 5. IL-4 producing CD4
+ and IgE
+ cells from foals and adult horses were measured by ﬂow
cytometry. PBMC were stimulated with PMA and ionocmycin. The cells were stained for intracellular IL-4
and cell surface CD4 or IgE. (A) A representative image from a horse of each age group is shown. (B) The
total number of IL-4
+ cells was normalized to 100% and the relative numbers of IL-4 producing CD4
+ cells
(%) were calculated for each horse. Medians are shown as horizontal lines within the data points of each
group. *** p < 0.001; ns = not signiﬁcant.
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of all three cytokines, IFN-c, IL-4 and IL-10, is
quantitatively lower in foals than in adult
horses.
PMA is a structural analog to diacylglycerol
and activates protein kinase C (PKC). PMA can
activate different cell populations via this path-
way, including T cells, B cells, basophils, mast
cells and various other cell types. In Tcells, the
same intracellular signaling pathway is used
following antigen-speciﬁc T cell receptor
(TCR) activation resulting in T cell differentia-
tion and cytokine production. Similarly, PMA
can activate T cells independent of their TCR
speciﬁcity by directly inducing PKC and cyto-
kine production [45]. Thus, PMA stimulation
of PBMC results in a polyclonal cytokine
response of the naı ¨ve T cell pool, yielding
insight into the general potential of these cells
to produce cytokines. However, the quantita-
tively reduced cytokine response to PMA in
foals compared to adult horses does not neces-
sarily mean that antigen-speciﬁc T cell activa-
tion would also result in a non-protective
immune response in foals. For example, by
comparing responses to R. equi infection in
healthy foals and adult horses, monocyte-
derived dendritic cells from foals responded
with increased IL-12 mRNA expression, the
innate cytokine which triggers Th1 cell devel-
opment [11]. Healthy foals also showed an
up-regulation of IFN-c mRNA, a decreased
expression of IL-4 and increased IFN-c/IL-4
transcript ratios in response to R. equi [16]. In
another pathogen model, the IFN-c production
in response to EHV-1 was found to be low in
foal PBMC but the EHV-1 induced IFN-c pro-
ducing cells were mainly protective CD8
+ CTL
[29, 31]. In contrast, aged horses which have a
higher susceptibility to EHV-1 infection,
showed a clear decrease in IFN-c producing
EHV-1 speciﬁc CTL [31]. Thus, the antigen-
speciﬁc T cell response to a speciﬁc pathogen
can still be sufﬁcient and protective in the foals
even if the response varies quantitatively from
adult horses.
Twenty years ago, Mosmann and Coffman
[27] published their famous studies on the
induction of Th1 and Th2 pathways in the
Leishmania major model in mice. Since then,
it is well accepted that the balance of Th cell
cytokines is crucial for the outcome of the adap-
tive immune response and the development of
immunity and protection to infectious diseases.
Today, this general concept still has important
implications for vaccine development. Classic
vaccine formulations were often found to be
less effective in young foals. To develop protec-
tive vaccine strategies for foals early in life, it is
important to understand differences and similar-
ities of neonatal and adult immune responses in
healthy horses. One way to analyze qualitative
parameters of the adaptive immune response
is to determine the balance of cytokines pro-
duced by Th cells. Despite the quantitative
reduction of IFN-c produced by foal CD4
+ cells
compared to adult cells, our data demonstrated
that the balance of Th1/Th2 cytokines in foals
was highly dependent on age and biased
towards the Th1 phenotype. A reduced Th1/
Th2 cytokine proﬁle compared to adults was
only observed on day 5 after birth and was
mainly due to the peak in IL-4 production by
IgE
+ cells. In 6 and 12 weeks old foals, the T
cell response showed a clear Th1 dominated
cytokine proﬁle. In addition, adult-like IFN-c/
IL-10 ratios and the IFN-c production by Th
cells or CTL were evident within 5 days of
birth. Collectively these data demonstrated that
Tcells from equine neonates and foals are com-
petent in mounting Th1, CTL and TR1
responses that are qualitatively similar to those
observed in adult horses.
In addition, we found that equine neonates
and foals had an impaired Th2 response that
did not reach adult-like levels even by 3 months
of age and that the IL-4 production in neonates
and very young foals originated mainly from
IgE
+ basophils and not from Tcells. These data
challenge the dogma that equine neonates and
foals mount Th2 biased immune responses [5,
23, 26]. Similarly, non-stimulated neonatal
basophils isolated around day 5 after birth pro-
duced IL-4 and increased IL-4 secretion from
these cells was observed after stimulation with
anti-IgE [44]. Recent reports derived from
humans or experimental mouse models provide
increasing evidence that basophils are the most
important innate inducers of Th2 cell differenti-
ation during allergic conditions and responses
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(page number not for citation purpose) Page 11 of 14to parasites by providing the early IL-4 signal
that initiates the polarization of Th cells towards
the Th2 phenotype [10, 24, 28, 34]. Similarly,
basophil derived IL-4 could provide the innate
trigger to initiate Th2 differentiation in equine
neonatal T cells. However, although IL-4 from
basophils was detectable during the ﬁrst week
of life, we observed a clear delay in the devel-
opment of IL-4 producing Th cells in foals.
Thus, an immediate or broad inﬂuence of the
early IL-4 production by basophils on the
development of Th2 immunity is rather
unlikely.
Overall, the Tcell response in neonatal foals
to PMA reported here and by others using anti-
gen speciﬁc stimuli [16, 29, 31] more closely
resembled immune responses in human as com-
pared to murine neonates. Human neonatal T
cells were also found to develop weak IL-2
and IFN-c responses and proliferated poorly
in response to TCR mediated stimulation. How-
ever, if human neonatal T cells were stimulated
by TCR-independent pathways, such as cross-
linking of CD3 plus recombinant IL-6 or IL-
12 or anti-CD28 antibody, adult-like T cell
responses were observed [2].
Insummary,ourresultsprovideanewpointof
view on the development of Th cell responses
and the balances of Th1, Th2 and TR1c y t o k i n e s
in healthy equine neonates and foals.
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